Commodore Capital LP Diversified Active

CIK: 0001831942 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $1,495,488 (100.0% shares, 0.0% debt)

Holdings (39)

— MERUS N V 13.1%

Value ($000) $196,331 Shares 4,360,000 Est. Cost $24.78 Unrealized —

VERA VERA THERAPEUTICS INC 9.1%

Value ($000) $136,475 Shares 3,165,000 Est. Cost $8.35 Unrealized +326.7%

NUVL NUVALENT INC 7.5%

Value ($000) $111,716 Shares 1,487,756 Est. Cost $45.30 Unrealized +75.7%

XENE XENON PHARMACEUTICALS INC 6.2%

Value ($000) $93,323 Shares 2,167,793 Est. Cost $27.44 Unrealized +67.6%

SYRE SPYRE THERAPEUTICS INC 4.8%

Value ($000) $71,463 Shares 1,884,084 Est. Cost $13.74 Unrealized +110.9%

ELVN ENLIVEN THERAPEUTICS INC 4.7%

Value ($000) $69,889 Shares 3,973,245 Est. Cost $18.48 Unrealized -17.0%

PCVX VAXCYTE INC 3.9%

Value ($000) $58,747 Shares 860,000 Est. Cost $46.14 Unrealized +50.1%

— MIND MEDICINE MINDMED INC 3.7%

Value ($000) $54,833 Shares 5,833,333 Est. Cost $9.40 Unrealized —

— ALPINE IMMUNE SCIENCES INC 3.6%

Value ($000) $54,505 Shares 1,375,000 Est. Cost $9.30 Unrealized —

ARVN ARVINAS INC 3.5%

Value ($000) $52,632 Shares 1,275,000 Est. Cost $27.76 Unrealized +57.4%

RYTM RHYTHM PHARMACEUTICALS INC 3.0%

Value ($000) $45,497 Shares 1,050,000 Est. Cost $22.39 Unrealized +95.4%

COGT COGENT BIOSCIENCES INC 2.9%

Value ($000) $43,176 Shares 6,425,000 Est. Cost $8.56 Unrealized -27.8%

PHVS PHARVARIS N V 2.7%

Value ($000) $39,865 Shares 1,725,000 Est. Cost $23.63 Unrealized +12.4%

CLDX CELLDEX THERAPEUTICS INC NEW 2.4%

Value ($000) $36,366 Shares 866,468 Est. Cost $32.99 Unrealized +24.5%

NKTX NKARTA INC 2.3%

Value ($000) $34,214 Shares 3,165,000 Est. Cost $3.66 Unrealized +183.8%

VRDN VIRIDIAN THERAPEUTICS INC 2.3%

Value ($000) $33,876 Shares 1,934,653 Est. Cost $17.59 Unrealized +10.2%

CELC CELCUITY INC 2.2%

Value ($000) $33,609 Shares 1,555,954 Est. Cost $18.27 Unrealized -12.6%

KURA KURA ONCOLOGY INC 2.2%

Value ($000) $32,528 Shares 1,525,000 Est. Cost $14.92 Unrealized +30.3%

CCCC C4 THERAPEUTICS INC 1.9%

Value ($000) $27,863 Shares 3,410,384 Est. Cost $2.28 Unrealized +239.9%

ORIC ORIC PHARMACEUTICALS INC 1.8%

Value ($000) $27,500 Shares 2,000,000 Est. Cost $11.88 Unrealized 0.0%

ABVX ABIVAX SA 1.8%

Value ($000) $27,099 Shares 1,895,003 Est. Cost $10.70 Unrealized —

— PERSPECTIVE THERAPEUTICS INC 1.7%

Value ($000) $25,053 Shares 21,052,631 Est. Cost $1.19 Unrealized —

IMVT IMMUNOVANT INC 1.6%

Value ($000) $24,264 Shares 750,990 Est. Cost $14.46 Unrealized +152.4%

KYTX KYVERNA THERAPEUTICS INC 1.5%

Value ($000) $22,659 Shares 912,189 Est. Cost $27.84 Unrealized 0.0%

ENGN ENGENE HOLDINGS INC 1.4%

Value ($000) $21,188 Shares 1,250,000 Est. Cost $12.24 Unrealized 0.0%

APGE APOGEE THERAPEUTICS INC 1.3%

Value ($000) $19,271 Shares 290,000 Est. Cost $25.01 Unrealized +74.5%

CABA CABALETTA BIO INC 1.3%

Value ($000) $18,766 Shares 1,100,000 Est. Cost $7.66 Unrealized +180.3%

AUTL AUTOLUS THERAPEUTICS PLC 1.0%

Value ($000) $14,674 Shares 2,300,000 Est. Cost $6.38 Unrealized —

— THIRD HARMONIC BIO INC 0.8%

Value ($000) $11,800 Shares 1,250,000 Est. Cost $11.87 Unrealized —

NGNE NEUROGENE INC 0.7%

Value ($000) $10,180 Shares 200,000 Est. Cost $33.40 Unrealized 0.0%

— ADVERUM BIOTECHNOLOGIES INC 0.6%

Value ($000) $9,295 Shares 657,333 Est. Cost $14.14 Unrealized —

VTGN VISTAGEN THERAPEUTICS INC 0.6%

Value ($000) $8,316 Shares 1,575,000 Est. Cost $4.44 Unrealized +8.3%

SNDX SYNDAX PHARMACEUTICALS INC 0.5%

Value ($000) $7,589 Shares 318,851 Est. Cost $22.30 Unrealized 0.0%

SLNO SOLENO THERAPEUTICS INC 0.5%

Value ($000) $7,256 Shares 169,533 Est. Cost $6.05 Unrealized +647.3%

BBOT HELIX ACQUISITION CORP II 0.3%

Value ($000) $5,200 Shares 500,000 Est. Cost $10.35 Unrealized 0.0%

MGNX MACROGENICS INC 0.3%

Value ($000) $4,343 Shares 295,020 Est. Cost $15.11 Unrealized 0.0%

— ADICET BIO INC 0.2%

Value ($000) $3,230 Shares 1,374,320 Est. Cost $2.35 Unrealized —

SABS SAB BIOTHERAPEUTICS INC 0.1%

Value ($000) $832 Shares 183,174 Est. Cost $8.38 Unrealized -34.3%

— DBV TECHNOLOGIES S A 0.0%

Value ($000) $69 Shares 92,687 Est. Cost $0.00 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	MERUS N V	4,360,000	$196,331	13.1%	$24.78	—	COM	N5749R100
VERA	VERA THERAPEUTICS INC	3,165,000	$136,475	9.1%	$8.35	+326.7%	CL A	92337R101
NUVL	NUVALENT INC	1,487,756	$111,716	7.5%	$45.30	+75.7%	COM	670703107
XENE	XENON PHARMACEUTICALS INC	2,167,793	$93,323	6.2%	$27.44	+67.6%	COM	98420N105
SYRE	SPYRE THERAPEUTICS INC	1,884,084	$71,463	4.8%	$13.74	+110.9%	COM NEW	00773J202
ELVN	ENLIVEN THERAPEUTICS INC	3,973,245	$69,889	4.7%	$18.48	-17.0%	COM	29337E102
PCVX	VAXCYTE INC	860,000	$58,747	3.9%	$46.14	+50.1%	COM	92243G108
—	MIND MEDICINE MINDMED INC	5,833,333	$54,833	3.7%	$9.40	—	COM NEW	60255C885
—	ALPINE IMMUNE SCIENCES INC	1,375,000	$54,505	3.6%	$9.30	—	COM	02083G100
ARVN	ARVINAS INC	1,275,000	$52,632	3.5%	$27.76	+57.4%	COM	04335A105
RYTM	RHYTHM PHARMACEUTICALS INC	1,050,000	$45,497	3.0%	$22.39	+95.4%	COM	76243J105
COGT	COGENT BIOSCIENCES INC	6,425,000	$43,176	2.9%	$8.56	-27.8%	COM	19240Q201
PHVS	PHARVARIS N V	1,725,000	$39,865	2.7%	$23.63	+12.4%	COM	N69605108
CLDX	CELLDEX THERAPEUTICS INC NEW	866,468	$36,366	2.4%	$32.99	+24.5%	COM NEW	15117B202
NKTX	NKARTA INC	3,165,000	$34,214	2.3%	$3.66	+183.8%	COM	65487U108
VRDN	VIRIDIAN THERAPEUTICS INC	1,934,653	$33,876	2.3%	$17.59	+10.2%	COM	92790C104
CELC	CELCUITY INC	1,555,954	$33,609	2.2%	$18.27	-12.6%	COM	15102K100
KURA	KURA ONCOLOGY INC	1,525,000	$32,528	2.2%	$14.92	+30.3%	COM	50127T109
CCCC	C4 THERAPEUTICS INC	3,410,384	$27,863	1.9%	$2.28	+239.9%	COM STK	12529R107
ORIC	ORIC PHARMACEUTICALS INC	2,000,000	$27,500	1.8%	$11.88	0.0%	COM	68622P109
ABVX	ABIVAX SA	1,895,003	$27,099	1.8%	$10.70	—	SPONSORED ADS	00370M103
—	PERSPECTIVE THERAPEUTICS INC	21,052,631	$25,053	1.7%	$1.19	—	COM	46489V104
IMVT	IMMUNOVANT INC	750,990	$24,264	1.6%	$14.46	+152.4%	COM	45258J102
KYTX	KYVERNA THERAPEUTICS INC	912,189	$22,659	1.5%	$27.84	0.0%	COM	501976104
ENGN	ENGENE HOLDINGS INC	1,250,000	$21,188	1.4%	$12.24	0.0%	COM	29286M105
APGE	APOGEE THERAPEUTICS INC	290,000	$19,271	1.3%	$25.01	+74.5%	COM	03770N101
CABA	CABALETTA BIO INC	1,100,000	$18,766	1.3%	$7.66	+180.3%	COM	12674W109
AUTL	AUTOLUS THERAPEUTICS PLC	2,300,000	$14,674	1.0%	$6.38	—	SPON ADS	05280R100
—	THIRD HARMONIC BIO INC	1,250,000	$11,800	0.8%	$11.87	—	COM	88427A107
NGNE	NEUROGENE INC	200,000	$10,180	0.7%	$33.40	0.0%	COM	64135M105
—	ADVERUM BIOTECHNOLOGIES INC	657,333	$9,295	0.6%	$14.14	—	COM NEW	00773U207
VTGN	VISTAGEN THERAPEUTICS INC	1,575,000	$8,316	0.6%	$4.44	+8.3%	COM	92840H400
SNDX	SYNDAX PHARMACEUTICALS INC	318,851	$7,589	0.5%	$22.30	0.0%	COM	87164F105
SLNO	SOLENO THERAPEUTICS INC	169,533	$7,256	0.5%	$6.05	+647.3%	COM	834203309
BBOT	HELIX ACQUISITION CORP II	500,000	$5,200	0.3%	$10.35	0.0%	CL A ORD SHS	G4444H101
MGNX	MACROGENICS INC	295,020	$4,343	0.3%	$15.11	0.0%	COM	556099109
—	ADICET BIO INC	1,374,320	$3,230	0.2%	$2.35	—	COM	007002108
SABS	SAB BIOTHERAPEUTICS INC	183,174	$832	0.1%	$8.38	-34.3%	COM NEW	78397T202
—	DBV TECHNOLOGIES S A	92,687	$69	0.0%	$0.00	—	SPONSORED ADR	23306J101